Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro

Radiation and Environmental Biophysics

Volumn 49, Issue 2, 2010, Pages 261-270

  Hille, Andrea ^a   Grüger, Susanne ^a   Christiansen, Hans ^a   Wolff, Hendrik A ^a   Volkmer, Beate ^b   Lehmann, Jörg ^c   Dörr, Wolfgang ^d   Rave Fränk, Margret ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Dermatology Centre Elbeklinikum Buxtehude   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL STUDIES; GROWTH STIMULATION; HEAD AND NECK; IN-VITRO; KERATINOCYTE GROWTH FACTORS; KERATINOCYTES; MALIGNANT CELLS; NATURAL SOURCES; NEUTRALIZING ANTIBODIES; PARACRINE; RADIATION RESPONSE; RADIOCHEMOTHERAPY; RADIOPROTECTION; RECEPTOR EXPRESSION; REGULATORY MECHANISM; SELECTIVE PROTECTION; SQUAMOUS CELL CARCINOMA; TUMOUR CELLS;

ANIMAL CELL CULTURE; ANTIBODIES; BIOACTIVITY; CELL PROLIFERATION; FIBROBLASTS; GROWTH KINETICS; PEPTIDES; RADIATION PROTECTION; TUMORS; WELL STIMULATION;

CELL CULTURE;

ANIMALIA;

ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; RECOMBINANT PROTEIN;

ARTICLE; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; KERATINOCYTE; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTIBODIES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 7; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECOMBINANT PROTEINS;

EID: 77954457748     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-010-0271-7     Document Type: Article

References (39)

1. Bansal GS, Cox HC, Marsh S, Gomm JJ, Yiangou C, Luqmani Y et al (1997) Expression of keratinocyte growth factor and its receptor in human breast cancer. Br J Cancer 75(11):1567-1574 (Pubitemid 27229045)
2. Beaven AW, Shea TC (2007) The effect of palifermin on chemotherapy and radiation therapy-induced mucositis: a review of the current literature. Support Cancer Ther 4(4):188-197
3. Belleudi F, Leone L, Nobili V, Raffa S, Francescangeli F, Maggio M et al (2007) Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways. Traffic 8(12):1854-1872
4. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106(3):761-771
5. Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Gluck S, Brizel HE et al (2008) Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. J Clin Oncol 26(15):2489-2496
6. Danilenko DM (1999) Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol 27(1):64-71
7. Dorr W (2003) Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 79(7):531-537
8. Dorr W, Noack R, Spekl K, Farrell CL (2001) Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. Int J Radiat Biol 77(3):341-347
9. Dorr W, Hamilton CS, Boyd T, Reed B, Denham JW (2002a) Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys 52(4):911-917
10. Dorr W, Spekl K, Farrell CL (2002b) Amelioration of acute oral mucositis by keratinocyte growth factor: fractionated irradiation. Int J Radiat Oncol Biol Phys 54(1):245-251
11. Dorr W, Spekl K, Farrell CL (2002c) The effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epithelium. Cell Prolif 35(Suppl 1):86-92
12. Dorr W, Bassler S, Reichel S, Spekl K (2005a) Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice. Int J Radiat Oncol Biol Phys 62(3):881-887
13. Dorr W, Heider K, Spekl K (2005b) Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF. Int J Radiat Biol 81(8):557-565
14. Dorr W, Reichel S, Spekl K (2005c) Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 75(1):99-105
15. Drugan CS, Stone A, Game SM, Prime SS (1997) The mitogenic effect of KGF and the expression of its cell surface receptor on cultured normal and malignant human oral keratinocytes and on contiguous fibroblasts. J Oral Pathol Med 26(7):327-333
16. Epstein JB, Klasser GD (2006) Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy. Expert Opin Emerg Drugs 11(2):353-373
17. Farrell CL, Bready JV, Rex KL, Chen JN, Di Palma CR, Whitcomb KL et al (1998) Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58(5):933-939
18. Farrell CL, Rex KL, Kaufman SA, Dipalma CR, Chen JN, Scully S et al (1999) Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol 75(5):609-620
19. Finch PW, Rubin JS (2006) Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 98(12):812-824
20. Fleischer G, Dorr W (2006) Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine. Strahlenther Onkol 182(10):567-575
21. Hille A, Rave-Frank M, Pradier O, Damm C, Dorr W, Jackel MC et al (2003) Effect of keratinocyte growth factor on the proliferation, clonogenic capacity and colony size of human epithelial tumour cells in vitro. Int J Radiat Biol 79(2):119-128
22. Jaal J, Dorr W (2007) Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction. Int J Radiat Oncol Biol Phys 69(2):528-533
23. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5):820-831
24. Khan WB, Shui C, Ning S, Knox SJ (1997) Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res 148(3):248-253
25. Kilic Y, Rajewski K, Dorr W (2007) Effect of post-exposure administration of keratinocyte growth factor (Palifermin) on radiation effects in oral mucosa in mice. Radiat Environ Biophys 46(1):13-19
26. Lombaert IM, Brunsting JF, Wierenga PK, Kampinga HH, de Haan G, Coppes RP (2008) Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool. Stem Cells 26(10):2595-2601
27. Meropol NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK et al (2003) Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J Clin Oncol 21(8):1452-1458
28. Ning S, Shui C, Khan WB, Benson W, Lacey DL, Knox SJ (1998) Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol Phys 40(1):177-187
29. Okunieff P, Li M, Liu W, Sun J, Fenton B, Zhang L et al (2001) Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma. Am J Clin Oncol 24(5):491-495
30. Parrott JA, Kim G, Mosher R, Skinner MK (2000) Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 167 (1-2): 77-87
31. Planz B, Aretz HT, Wang Q, Tabatabaei S, Kirley SD, Lin CW et al (1999) Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41(4):233-242
32. Shaoul R, Eliahu L, Sher I, Hamlet Y, Miselevich I, Goldshmidt O et al (2006) Elevated expression of FGF7 protein is common in human gastric diseases. Biochem Biophys Res Commun 350(4):825-833
33. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Buchler MW, Korc M (1995) Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 215(1):309-315
34. Slonina D, Hoinkis C, Dorr W (2001) Effect of keratinocyte growth factor on radiation survival and colony size of human epidermal keratinocytes in vitro. Radiat Res 156(6):761-766
35. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351(25):2590-2598
36. Suyama Y, Kubota Y, Yamashiro T, Ninomiya T, Koji T, Shirasuna K (2009) Expression of keratinocyte growth factor and its receptor in odontogenic keratocysts. J Oral Pathol Med 38(5):476-480
37. Watanabe M, Ishiwata T, Nishigai K, Moriyama Y, Asano G (2000) Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol Int 50(5):363-372
38. Yamayoshi T, Nagayasu T, Matsumoto K, Abo T, Hishikawa Y, Koji T (2004) Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis. J Pathol 204(1):110-118
39. Yoshino M, Ishiwata T, Watanabe M, Matsunobu T, Komine O, Ono Y et al (2007) Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells. Int J Oncol 31(4):721-728